Mayinglong Pharmaceutical Group Co Ltd (600993) — Cash Flow-to-Debt Ratio
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of CN¥139.20 Million could theoretically repay 0% of its total liabilities (CN¥909.82 Million) in one year. See 600993 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mayinglong Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Mayinglong Pharmaceutical Group Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see 600993 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Mayinglong Pharmaceutical Group Co Ltd. Check Mayinglong Pharmaceutical Group Co Ltd (600993) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.65x | CN¥600.44 Million | CN¥921.49 Million | ▲ +28.4% |
| 2024 | 0.51x | CN¥497.61 Million | CN¥980.66 Million | ▼ -19.4% |
| 2023 | 0.63x | CN¥604.07 Million | CN¥959.62 Million | ▲ +164.9% |
| 2022 | 0.24x | CN¥341.85 Million | CN¥1.44 Billion | ▼ -67.7% |
| 2021 | 0.73x | CN¥597.17 Million | CN¥812.72 Million | ▲ +138.9% |
| 2020 | 0.31x | CN¥282.99 Million | CN¥919.89 Million | ▼ -59.3% |
| 2019 | 0.76x | CN¥491.58 Million | CN¥650.49 Million | ▲ +40.9% |
| 2018 | 0.54x | CN¥308.24 Million | CN¥574.67 Million | ▼ -27.3% |
| 2017 | 0.74x | CN¥356.17 Million | CN¥482.99 Million | ▲ +47.7% |
| 2016 | 0.50x | CN¥239.60 Million | CN¥479.88 Million | ▲ +42.9% |
| 2015 | 0.35x | CN¥182.85 Million | CN¥523.31 Million | ▲ +52.3% |
| 2014 | 0.23x | CN¥111.67 Million | CN¥486.89 Million | ▼ -18.6% |
| 2013 | 0.28x | CN¥129.94 Million | CN¥461.22 Million | ▼ -31.8% |
| 2012 | 0.41x | CN¥169.25 Million | CN¥409.56 Million | ▲ +85.2% |
| 2011 | 0.22x | CN¥75.37 Million | CN¥337.70 Million | ▲ +728.6% |
| 2010 | -0.04x | CN¥-11.42 Million | CN¥321.68 Million | ▼ -106.3% |
| 2009 | 0.56x | CN¥216.11 Million | CN¥384.11 Million | ▲ +59.9% |
| 2008 | 0.35x | CN¥102.59 Million | CN¥291.46 Million | ▲ +1194.6% |
| 2007 | 0.03x | CN¥6.49 Million | CN¥238.53 Million | ▼ -91.0% |
| 2006 | 0.30x | CN¥75.27 Million | CN¥250.53 Million | ▼ -9.8% |
| 2005 | 0.33x | CN¥58.43 Million | CN¥175.45 Million | ▼ -19.6% |
| 2004 | 0.41x | CN¥54.19 Million | CN¥130.74 Million | ▼ -16.1% |
| 2003 | 0.49x | CN¥67.52 Million | CN¥136.61 Million | — |